Showing results (41-50 of 251) with videos related to

Sort By:
Pageof 26
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 19, 2011
Correlation between 18F-FDG uptake on PET and molecular biology in metastatic pulmonary tumorsKyoichi Kaira, Takehiro Okumura, Yasuhisa Ohde, et al.
Oncology Reports|November 1, 2013
¹⁸F-FDG uptake on PET is a predictive marker of thymidylate synthase expression in patients with thoracic neoplasmsKyoichi Kaira, Nobuyuki Yamamoto, Masahiro Endo, et al.
International Journal of Clinical Oncology|April 7, 2017
Response to the treatment immediately before nivolumab monotherapy may predict clinical response to nivolumab in patients with non-small cell lung cancerHaruki Kobayashi, Shota Omori, Kazuhisa Nakashima, et al.
Investigational New Drugs|July 5, 2018
Leptomeningeal recurrence after long-term alectinib therapy for non-small cell lung cancer harboring an EML4-ALK fusion proteinTakahisa Kawamura, Haruyasu Murakami, Haruki Kobayashi, et al.
Japanese Journal of Clinical Oncology|August 17, 2018
Efficacy of second-line chemotherapy in poor-risk patients with refractory-relapsed small-cell lung cancerKazushige Wakuda, Haruki Kobayashi, Shota Omori, et al.
Anticancer Research|March 9, 2012
Interstitial lung disease associated with docetaxel in patients with advanced non-small cell lung cancerAkihiro Tamiya, Tateaki Naito, Satoru Miura, et al.
Lung Cancer (Amsterdam, Netherlands)|June 24, 2010
Evaluation of the efficacy and safety of chemotherapy for patients with wet stage IIIB/IV non-small-cell lung cancer aged 80 years old or moreAkihiro Tamiya, Tateaki Naito, Akira Ono, et al.
Anticancer Research|April 3, 2014
Phase II study of erlotinib for acquired resistance to gefitinib in patients with advanced non-small cell lung cancerAtsushi Horiike, Nobuyuki Yamamoto, Hisashi Tanaka, et al.
Pageof 26